| Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genetique de la Nephropathie Diabetique Study Group. Donnees Epidemiologiques sur le Syndrome d'Insulino-Resistance Study Group. Hadjadj S., Gallois Y., Simard G., Bouhanick B., Passa P., Grimaldi A., Drouin P., Tichet J., Marre M.
Nephrol. Dial. Transplant. 15:1971-1976(2000) · Mapped (17) |
| Association between high von willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. Lacquemant C., Gaucher C., Delorme C., Chatellier G., Gallois Y., Rodier M., Passa P., Balkau B., Mazurier C., Marre M. et al.
Kidney Int. 57:1437-1443(2000) · Mapped (6) |
| Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Velho G., Blanche H., Vaxillaire M., Bellanne-Chantelot C., Pardini V.C., Timsit J., Passa P., Deschamps I., Robert J.-J., Weber I.T. et al.
Diabetologia 40:217-224(1997) · UniProtKB (1) |
| Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. Garin M.C., James R.W., Dussoix P., Blanche H., Passa P., Froguel P., Ruiz J.
J. Clin. Invest. 99:62-66(1997) · Mapped (3) |
| Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. Byrne M.M., Sturis J., Clement K., Vionnet N., Pueyo M.E., Stoffel M., Takeda J., Passa P., Cohen D., Bell G.I.
J. Clin. Invest. 93:1120-1130(1994) |
| Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G.I., Zouali H., Lesage S., Velho G., Iris F., Passa P.
Nature 356:721-722(1992) · Mapped (4) |
| Human glucokinase gene: isolation, characterization, and identification of two missense mutations linked to early-onset non-insulin-dependent (type 2) diabetes mellitus. Stoffel M., Froguel P., Takeda J., Zouali H., Vionnet N., Nishi S., Weber I.T., Harrison R.W., Pilkis S.J., Lesage S. et al.
Proc. Natl. Acad. Sci. U.S.A. 89:7698-7702(1992) · UniProtKB (1) |
